Stereoselective C9-C10 Bond Formation in Steroid Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current synthetic methods for steroids and tetracyclic terpenoids are complex, inefficient, and unable to produce the necessary oxygenated/functionalized compositions required for modern drug development, particularly in creating glucocorticoid receptor modulators for treating glucocorticoid-dependent conditions like cancer and hypercortisolism.

Innovation Solution

Development of concise and stereoselective synthetic methods for polycyclic compounds, including tetracyclic steroid derivatives with a C19 steroidal scaffold, which serve as glucocorticoid receptor modulators, using hydroxy group protection, protodesilylation, and Brønsted acid-mediated regio- and stereoselective Friedel-Crafts cyclization to form the C9-C10 bond and establish quaternary centers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current synthetic methods are used for steroids and tetracyclic terpenoids, then existing compounds can be produced, but the synthesis is complex and inefficient and cannot produce the necessary oxygenated/functionalized compositions required for modern drug development

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidsynthetic route complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The synthesis is divided into discrete modular steps including hydroxy group protection, protodesilylation, and Brønsted acid-mediated Friedel-Crafts cyclization. Each step is optimized independently to achieve high stereoselection at C9-C10 bond formation, allowing for efficient assembly of complex steroidal scaffolds with quaternary centers

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The methodology employs specific parameter changes including use of Brønsted acids with controlled strength, precise temperature control during cyclization, and selective protecting group chemistry to achieve high stereoselection. These parameter optimizations enable concise synthesis routes that produce oxygenated/functionalized steroidal compositions required for drug development

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If stereoselective synthesis methods are implemented to create quaternary centers at C9, then high stereoselection is achieved, but the synthetic procedure becomes more complex

Engineering Contradiction:
ImprovestereoselectionVSAvoidsynthetic procedure complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

Hydroxy groups are protected and silyl groups are removed before the key cyclization step to pre-organize the substrate for stereoselective C9-C10 bond formation. This preliminary preparation ensures that the Friedel-Crafts cyclization proceeds with high stereoselection at the quaternary C9 center without requiring additional complex steps later

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Brønsted acids serve as intermediaries to mediate the Friedel-Crafts cyclization reaction, enabling stereoselective C9-C10 bond formation. The acid catalyst facilitates the reaction through a well-defined mechanism that controls stereochemistry at the quaternary center, achieving high manufacturing precision through a manageable procedural step

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If glucocorticoid receptor modulators are developed for treating glucocorticoid-dependent conditions, then treatment efficacy improves, but side effects may increase

Engineering Contradiction:
Improvetreatment efficacyVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The synthesized glucocorticoid receptor modulators are designed with specific local functional groups and stereochemistry at key positions (particularly C9 quaternary centers) to optimize binding affinity and selectivity. This local structural optimization enables potent GR modulation for treating conditions like cancer and hypercortisolism while potentially reducing off-target effects through precise molecular design

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These methods enable the production of compounds with high stereoselection, acting as potent glucocorticoid receptor antagonists, effectively treating glucocorticoid-dependent conditions such as cancer and hypercortisolism with improved efficiency and reduced side effects.

Implementation Method 1

Brønsted acid-mediated regio- and stereoselective Friedel-Crafts cyclization to form the C9-C10 bond and establish quaternary centers

Methodology Applied
Scientific EffectFriedel-Crafts cyclization: Catalysis

Implementation Method 2

hydroxy group protection, protodesilylation, and Brønsted acid-mediated regio- and stereoselective Friedel-Crafts cyclization

Methodology Applied
Scientific EffectProtecting group chemistry: Chemical Bonding

Data Source

PatentUS20240228527A1Stereoselective c9-c10 bond formation
Publication Date: 2024.07.11 TRUSTEES OF DARTMOUTH COLLEGE THE
  • US20240228527A1 patent drawing
  • US20240228527A1 patent drawing
  • US20240228527A1 patent drawing

AI summary

The present disclosure relates to synthetic methods for preparing a 9-alpha-substituted or a 9-beta-substituted steroid-like compound. In particular, the disclosure relates to methods for generating a steroidal C9-C10 bond and establishing stereochemistry at C9 in such compounds. The methods provide high levels of stereoselection in the C9-C10 bond forming process. Compounds synthesized by such methods can be used as nuclear hormone receptor modulators.